Awake Plastic Surgery Procedures: The Use of a Sufentanil Sublingual Tablet to Improve Patient Experience

Awake Plastic Surgery Procedures: The Use of a Sufentanil Sublingual Tablet to Improve Patient Experience

Abstract BackgroundAwake plastic surgery performed under minimal sedation has advantages including patient preference, affordability, and easier recovery compared to when performed under deeper sedation. Commonly used oral analgesics may not be adequate for awake pr...

Full description

Bibliographic Details
Main Author:	Hisham Seify
Format:	Article
Language:	English
Published:	Oxford University Press 2022-01-01
Series:	Aesthetic Surgery Journal Open Forum
Online Access:	https://academic.oup.com/asjopenforum/article-lookup/doi/10.1093/asjof/ojab056

Similar Items

Commentary on: Awake Plastic Surgery Procedures: The Use of a Sufentanil Sublingual Tablet to Improve Patient Experience
by: Mikaela L Kislevitz, et al.
Published: (2022-02-01)

Sufentanil Sublingual Tablet Reduces Postoperative Opioid Use Following Outpatient Plastic Surgery
by: Hisham Seify
Published: (2022-05-01)

Evaluation of sufentanil sublingual tablet 30 mcg for perioperative pain management of in-office rhinology procedures
by: Ashley Sikand, et al.
Published: (2023-06-01)

Sufentanil sublingual tablet system (Zalviso®) as an effective analgesic option after thoracic surgery: An observational study
by: Costa Fabio, et al.
Published: (2019-01-01)

Sublingual sufentanil for postoperative pain relief: first clinical experiences
by: Meijer F, et al.
Published: (2018-05-01)

Sublingual Sufentanil Tablet System (SSTS-Zalviso<sup>®</sup>) for Postoperative Analgesia after Orthopedic Surgery: A Retrospective Study
by: Andrea Angelini, et al.
Published: (2022-11-01)

Sublingual sufentanil tablet system Zalviso® for postoperative analgesia after knee replacement in fast track surgery: a pilot observational study
by: Marco Scardino, et al.
Published: (2018-03-01)

Sufentanil Sublingual Tablet System (SSTS) for the management of postoperative pain after major abdominal and gynecological surgery within an ERAS protocol: an observational study
by: Turi S, et al.
Published: (2019-07-01)

Sublingual Sufentanil: an option for pre-hospital pain management in trauma patients
by: Gianluca Pucciarelli, et al.
Published: (2023-09-01)

Sufentanil sublingual tablet system for enhanced recovery after total knee arthroplasty: a prospective observational case study
by: Emmanuel Rineau, et al.
Published: (2022-10-01)

Patient and Healthcare Professional Satisfaction Ratings and Safety Profile of Sufentanil Sublingual Tablets for Treatment of Acute Pain: A Pooled Demographic Analysis
by: Leiman D, et al.
Published: (2021-03-01)

Sufentanil sublingual tablet system versus oral oxycodone for management of postoperative pain in enhanced recovery after surgery pathway for total knee arthroplasty: a randomized controlled study
by: Emmanuel Noel, et al.
Published: (2020-11-01)

Sublingual Sufentanil versus Standard-of-Care (Patient-Controlled Analgesia with Epidural Ropivacaine/Sufentanil or Intravenous Morphine) for Postoperative Pain Following Pancreatoduodenectomy: A Randomized Trial
by: Groen JV, et al.
Published: (2022-06-01)

The statistical analyses of the study “Sufentanil Sublingual Tablet System (SSTS) for the management of postoperative pain after major abdominal and gynecological surgery within an ERAS protocol: an observational study”[Letter]
by: Wang X, et al.
Published: (2019-09-01)

The Statistical Analyses Of The Study “Sufentanil Sublingual Tablet System (SSTS) For The Management Of Postoperative Pain After Major Abdominal And Gynecological Surgery Within An ERAS Protocol: An Observational Study” [Response To Letter]
by: Turi S, et al.
Published: (2019-10-01)

The Preparation and Evaluation of Cyanocobalamin Mucoadhesive Sublingual Tablets
by: Anwar Ma’ali, et al.
Published: (2023-10-01)

Preparation and Evaluation of Telmisartan Solid Dispersion as Sublingual Tablets
by: Hiba Ayad Aziz, et al.
Published: (2024-01-01)

Comparative study of sufentanil and fentanyl for anesthesia in neurosurgical procedure
by: Jing⁃hua JIAO, et al.
Published: (2010-08-01)

Dexmedetomidine-midazolam versus Sufentanil-midazolam for Awake Fiberoptic Nasotracheal Intubation: A Randomized Double-blind Study
by: Cheng-Wen Li, et al.
Published: (2015-01-01)

Improvement of Resveratrol Permeation through Sublingual Mucosa: Chemical Permeation Enhancers versus Spray Drying Technique to Obtain Fast-Disintegrating Sublingual Mini-Tablets
by: Giulia Di Prima, et al.
Published: (2021-08-01)

Preference for sublingual immunotherapy with tablets in a Spanish population with allergic rhinitis
by: Mette Bøgelund, et al.
Published: (2022-02-01)

Carbonic acid tablets promote submandibular-sublingual salivary secretion in humans
by: Kenkichi Yamamoto, et al.
Published: (2020-11-01)

Formulation of sublingual promethazine hydrochloride tablets for rapid relief of motion sickness
by: Hamad S Alyami, et al.
Published: (2021-05-01)

Plasticity of cognitive functions before and after awake brain tumor surgery
by: Djaina Satoer, et al.
Published: (2015-04-01)

Efficacy of Japanese cedar pollen sublingual immunotherapy tablets for Japanese cypress pollinosis
by: Tomoya Kurokawa, MD, PhD, et al.
Published: (2023-05-01)

Enhancing Sublingual Tablet Quality through QbD: Current Trends and Insights"
by: Deepak Joshi, et al.
Published: (2023-09-01)

Safety profile and immunological response of dual sublingual immunotherapy with house dust mite tablet and Japanese cedar pollen tablet
by: Minoru Gotoh, et al.
Published: (2020-01-01)

Preliminary experience in Awake Surgery: Functional recovery profile
by: Abderrahim Bouadel, et al.
Published: (2022-09-01)

Esketamine combined with sufentanil versus sufentanil in patient-controlled intravenous analgesia: a meta-analysis
by: Manman Yao, et al.
Published: (2024-02-01)

Satisfaction and quality of life of allergic patients following sublingual five-grass pollen tablet immunotherapy in Spain
by: Darío Antolín-Amerigo, et al.
Published: (2017-11-01)

Guidelines for Awake Surgery
by: Guidelines Committee of the Japan Awake Surgery Conference
Published: (2024-01-01)

Preclinical Safety and Pharmacokinetics of Heat Stable Oxytocin in Sublingual Fast-Dissolving Tablet Formulation
by: Changcheng Zhu, et al.
Published: (2022-04-01)

Worldwide surveys on anaphylaxis to sublingual immunotherapy with house dust mite tablets are urgently needed
by: Ralph Mösges, et al.
Published: (2021-03-01)

ANESTHETIC EFFECT OF PROPOFOL COMBINED WITH ESKETAMINE AND SUFENTANIL IN HYSTEROSCOPIC SURGERY
by: YAN Rubing, SUN Jingbo, HAN Shuai, SHI Jianwen, CHU Haichen, LIANG Yongxin
Published: (2023-06-01)

Intrathecal sufentanil or fentanyl as adjuvants to low dose bupivacaine in endoscopic urological procedures
by: Shikha Gupta, et al.
Published: (2013-01-01)

Sufentanil: a risk factor for lactic acidosis in patients after heart valve surgery
by: Yu-Fei Zhan, et al.
Published: (2022-09-01)

Allergen Release Profiles of Fast-Dissolving Freeze-Dried Orodispersible Sublingual Allergy Immunotherapy Tablets
by: Takashi Yamamoto, PhD, et al.
Published: (2022-01-01)

Efficacy of a house dust mite sublingual immunotherapy tablet as add-on dupilumab in asthma with rhinitis
by: Makoto Hoshino, et al.
Published: (2022-10-01)

Minimization of ragweed allergy immunotherapy costs through use of the sublingual immunotherapy tablet in Canadian children with allergic rhinoconjunctivitis
by: Anne K. Ellis, et al.
Published: (2023-01-01)

Epinephrine in Anaphylaxis: Preclinical Study of Pharmacokinetics after Sublingual Administration of Taste-Masked Tablets for Potential Pediatric Use
by: Ousama Rachid, et al.
Published: (2018-02-01)